Pharmaceutical companies operate across some of the most regulated and complex administrative environments in any industry. Between FDA submissions, medical information requests, commercial operations, healthcare professional outreach, and internal compliance tracking, the volume of administrative work is enormous. A pharmaceutical company virtual assistant helps departments across the organization manage that volume without adding to permanent headcount.
Administrative Pressure Across Pharma Functions
According to McKinsey & Company's 2024 pharmaceutical operations report, administrative and support functions account for approximately 22% of total operating costs at mid-size pharmaceutical companies. For a company with $500 million in annual revenue, that translates to roughly $110 million per year in overhead—much of which is driven by scheduling, document management, reporting, and coordination tasks that don't require a degreed scientist or licensed professional to execute.
The pressure to reduce selling, general, and administrative (SG&A) expenses has intensified as payers push back on pricing and pipeline attrition rates remain stubbornly high. Virtual assistants represent one of the most straightforward cost reduction levers available.
Where Pharma VAs Add the Most Value
Medical affairs support — Coordinating key opinion leader (KOL) interactions, scheduling advisory board meetings, tracking publication timelines, and managing medical information request queues.
Regulatory affairs coordination — Maintaining regulatory calendars, preparing submission packages, tracking agency correspondence, and organizing eCTD document sets in systems like Veeva Vault.
Commercial operations — Managing field force schedules, processing sample accountability reports, coordinating speaker program logistics, and supporting territory planning.
Market access and HEOR — Scheduling payer meetings, organizing dossier materials, tracking formulary review timelines, and coordinating with outcomes research vendors.
Clinical operations admin — Following up with clinical trial sites on document collection, tracking enrollment reports, and managing ClinicalTrials.gov update schedules.
Executive and leadership support — Calendar management, board meeting preparation, travel coordination, and internal communications for senior leadership teams.
Compliance Is a Non-Negotiable
Pharmaceutical virtual assistants must operate within strict compliance frameworks. Any VA working in pharma needs to understand the basics of the PhRMA Code, HIPAA, adverse event reporting obligations, and the Sunshine Act (Open Payments). They should be comfortable working within validated document management systems and following SOPs for communication and data handling.
Stealth Agents trains VAs who work in pharmaceutical environments on these frameworks before placement. Industry-naive VAs in pharma settings create compliance exposure—a risk that companies should not accept in exchange for cost savings.
The Case for a Blended Model
Many pharmaceutical companies are moving toward a blended staffing model: a smaller permanent administrative headcount supplemented by virtual assistants who can flex up during high-demand periods—regulatory submission cycles, product launches, conference seasons, and annual planning processes. This model reduces fixed overhead while maintaining the capacity to handle peak workloads.
A product launch, for example, might require 60 to 90 days of intensive administrative support for commercial teams: coordinating with ad agencies, managing HCP outreach lists, scheduling sales force training sessions, and tracking promotional material approvals. Rather than hiring a full-time coordinator for a temporary workload spike, companies can bring in a trained pharmaceutical VA for the duration.
Stealth Agents works with commercial, medical, and regulatory teams at pharmaceutical companies to provide virtual assistants who are ready to contribute from day one. Visit Stealth Agents to discuss staffing options for your department.
Managing the Handoff
The most common failure mode for pharmaceutical VAs is an unclear scope of work. Departments that onboard a VA without defining communication channels, document access protocols, and task ownership tend to underutilize the resource. A structured onboarding process—covering the tools used, the compliance requirements, and the priority task list—typically produces results within the first two weeks.
Department heads who treat a VA as a junior team member with defined responsibilities, rather than a general administrative resource on standby, consistently report higher satisfaction and better output.
Sources
- McKinsey & Company, Pharmaceutical Operations Benchmarking Report, 2024
- PhRMA, Code on Interactions with Health Care Professionals, 2022
- IQVIA, Global Pharmaceutical Industry Overview, 2025
- FDA, Open Payments / Sunshine Act reporting data, 2025